The Flow Cytometry Core Facility (FCCF) at H. Lee Moffitt Cancer Center &Research Institute was established in 1990 to provide a centralized flow cytometry service for Cancer Center members and University of South Florida faculty with cancer related research interests. Flow cytometry is an indispensable analytical tool for cell biology, immunology, and translational research efforts at the Cancer Center. This technology provides a means for rapidly and accurately analyzing multiple characteristics of biological particles, as well as the ability to rapidly isolate and purify cell populations of interest for the purpose of assessing immunological function and molecular distinctions, cell culture cloning, and animal transplantation studies. The FCCF is staffed with highly trained instrument specialists with a combined 21 years of researchbased flow cytometry experience. The facility houses five benchtop analyzers, two high-speed cell sorters, a bead array analyzer, an automated bead sorter, and a fluorescent microscope. The FCCF provides several services including multi-parameter analysis, cell sorting, data analysis and graphics programs, instrument training, project consultation, flow cytometry courses, and application workshops. It also houses a current literature base including cytometry journals and textbooks;vendor information on instrumentation, reagents, and services;and handbooks on flow cytometry-based methodology, procedures and techniques. Overall usage in the FCCF has increased more than 180% since the 2000 CCSG submission as a result of investigator recruitment, increased instrument capacity, and the initiative to train users to operate the benchtop cytometers, which allows them unlimited independent access. Over 39 peer-reviewed investigators across all research programs routinely access the FCCF, totaling 88% usage of acquisition service, 85% usage for cell sorting, and 80% of service training. Usage is expected to grow with investigator recruitment over the next few years. The Core Facility provides critical support for the scientific programs at the Cancer Center by giving investigators access to state-of-the-art instrumentation, cutting-edge cytometry applications, and exceptionally trained staff committed to contributing to outstanding scientific research efforts to understand and control cancer biology.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
H. Lee Moffitt Cancer Center & Research Institute
United States
Zip Code
Davis, Stacy N; Govindaraju, Swapamthi; Jackson, Brittany et al. (2018) Recruitment Techniques and Strategies in a Community-Based Colorectal Cancer Screening Study of Men and Women of African Ancestry. Nurs Res 67:212-221
Martínez, Úrsula; Brandon, Thomas H; Sutton, Steven K et al. (2018) Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psychooncology 27:2104-2110
Perales-Puchalt, Alfredo; Perez-Sanz, Jairo; Payne, Kyle K et al. (2018) Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J Leukoc Biol 103:799-805
Nelson, Ashley M; Jim, Heather S L; Small, Brent J et al. (2018) Sleep disruption among cancer patients following autologous hematopoietic cell transplantation. Bone Marrow Transplant 53:307-314
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Kasting, Monica L; Giuliano, Anna R; Reich, Richard R et al. (2018) Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015. Cancer Epidemiol Biomarkers Prev 27:503-513
Denson, Aaron; Burke, Nancy; Wapinsky, Georgine et al. (2018) Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials. Am J Clin Oncol 41:133-139
Betts, Brian C; Bastian, David; Iamsawat, Supinya et al. (2018) Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. Proc Natl Acad Sci U S A 115:1582-1587
Pidala, Joseph; Beato, Francisca; Kim, Jongphil et al. (2018) In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation. Haematologica 103:531-539
Hampras, S S; Tommasino, M; Zhao, Y et al. (2018) Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation. Br J Dermatol :

Showing the most recent 10 out of 1254 publications